Sep 4, 2026 · 29 min
AI bets expand from chips to platforms and hair-loss drugs
Nvidia Buys Hugging Face for $12.9B & Pharma Companies are Bullish on Baldness
The episode connects autonomous vehicles, AI infrastructure, biotechnology, and shifting consumer culture to show where major bets are forming.
- 1Tesla’s CyberCab launch remains small, leaving the company a substantial gap to close against Waymo in autonomous taxis.
- 2NVIDIA’s reported Hugging Face acquisition signals a strategy to build beyond chips and deeper into the AI ecosystem.
- 3Pharmaceutical investors increasingly view hair-loss treatments as a market with weight-loss-drug-scale potential.
Don't miss
The hosts connect pharmaceutical interest in hair-loss treatments to the scale and investor excitement of the weight-loss-drug boom.
The brief
Tesla’s CyberCab has officially launched, but the rollout is small, Elon Musk was absent, and the vehicle still faces regulatory and manufacturing hurdles before autonomous taxis can scale.
The reported $12.9 billion NVIDIA-Hugging Face deal reflects a broader strategy: move beyond chips and acquire a larger role in the software and platform layer of AI.
Hair-loss treatments are drawing investor attention as drugmakers pursue different approaches to a huge market, evoking the commercial promise of the weight-loss-drug boom.
The hosts also examine Burning Man’s aging, wealthier audience and a co-founder’s criticism that the festival has become a luxury spectacle.
A tribute to Gloria Steinem corrects the familiar misattribution of the “fish need a bicycle” line, before the show closes with AI outages and Barilla’s Goodles acquisition.
Featuring
An Unexpected Life
AnthropicBooks & mentions
Listen to the full episode and explore every guest, topic, and moment on PodLume.